Home
About us
Editorial board
Ahead of print
Browse Articles
Search
Submit article
Instructions
Subscribe
Contacts
Login
Advanced Search
Users Online: 288
» Articles published in the past year
To view other articles click corresponding year from the navigation links on the left side.
All
|
Case Report
|
Case Reports
|
Editorial
|
Erratum
|
Letter To Editor
|
Letters to Editor
|
Mini Review
|
Notice of Retraction
|
Original Article
|
Original Articles
|
Review Article
|
Review Articles
|
Short Communication
|
Short Communications
|
Systematic Review
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
Show all abstracts
Show selected abstracts
Export selected to
Add to my list
Review Article:
Incidence of nonmelanoma skin cancer in renal transplant recipients: A systematic review and meta-analysis
Mohammad Matinfar, Shahrzad Shahidi, Awat Feizi
J Res Med Sci
2018, 23:14 (20 February 2018)
DOI
:10.4103/jrms.JRMS_817_17
PMID
:29531566
Background:
Nonmelanoma skin cancer (NMSC) in renal transplant recipients is common and associated with significant morbidity and mortality. The aim of the present systematic review and meta-analysis was to estimate the incidence of NMSC among renal transplant recipients.
Materials and Methods:
We systematically searched PubMed, Medline, Scopus, and Web of Science databases for studies that assessed the incidence of NMSC in renal transplant recipients using a combination of relevant keywords. Two independent investigators included studies and extracted necessary information. Random effect meta-analysis was used to estimate pooled incidence of NMSC with 95% confidence intervals (CIs).
Results:
Twenty-nine studies comprising 36,021 patients meet the criteria for the systematic review. The pooled incidence of NMSC in renal transplant recipients was 12.6% (95% CI: 12%–14%) with a majority of squamous cell carcinoma (SCC) 55% (95% CI: 47%–63%). The pooled estimate of the incidence rates of SCC and basal cell carcinoma was 2.7% (95% CI: 2%–3.4%) and 2.2% (95% CI: 1.5%–2.8%), respectively. Subgroup analysis per geographic location showed that pooled incidence of NMSC was 39.1% (95% CI: 26.3%–51.8%), 12.4% (95% CI: 8.8%–16%), and 1.2% (95% CI: 0.4%–2%) in Australia and New Zealand, Europe, and Middle East, respectively.
Conclusion:
The results of the current meta-analysis demonstrated that the incidence of NMSC in renal transplant recipients varies widely. Regarding the high incidence of NMSC among renal transplant recipients, awareness of associated risk factors and early diagnosis of the malignancy in the population is a major clinical need.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (11) ]
[PubMed]
[Sword Plugin for Repository]
Beta
Advanced Search
Month wise articles
Figures next to the month indicate the number of articles in that month
2022
July
[
2
]
May
[
1
]
April
[
1
]
March
[
2
]
February
[
1
]
2021
October
[
2
]
September
[
3
]
August
[
1
]
July
[
2
]
June
[
2
]
May
[
2
]
March
[
4
]
February
[
3
]
2020
December
[
1
]
November
[
3
]
August
[
2
]
July
[
1
]
June
[
4
]
April
[
2
]
March
[
1
]
2019
December
[
1
]
October
[
2
]
August
[
2
]
July
[
1
]
May
[
1
]
April
[
3
]
March
[
1
]
February
[
1
]
January
[
2
]
2018
December
[
1
]
October
[
2
]
September
[
1
]
August
[
1
]
July
[
2
]
June
[
2
]
April
[
1
]
March
[
3
]
February
[
1
]
January
[
3
]
2017
December
[
1
]
November
[
1
]
Sitemap
|
What's New
Feedback
|
Copyright and Disclaimer
|
Privacy Notice
© Journal of Research in Medical Sciences | Published by Wolters Kluwer -
Medknow
Online since 9
th
February, 2015